Add Causes of Type 1 Diabetes

2026-08-11 01:34:01 +08:00
parent b2ca654b53
commit 6f343ea738
1 changed files with 9 additions and 0 deletions
@@ -0,0 +1,9 @@
 <br>Researchers have uncovered a number of genetic regions that are linked closely with type 1 diabetes. Each of these is denoted with a name such as IDDM1. At least 18 different regions have been discovered and some of the genetic areas include an increased susceptibility for other autoimmune diseases such as rheumatoid arthritis and coeliac disease Whilst genetics offers clues as to why some people are more susceptible to type 1 diabetes, it doesn’t explain why some people with these genes develop type 1 diabetes and why others with these genes don’t. For example,  [Glyco Care Formulabitter melon extract](https://www.lawinjustice.com/node/38903) having an identical twin with type 1 diabetes gives you a statistically higher risk but it doesn’t necessarily mean you will develop the condition. Genetics does not explain either why people will develop type 1 diabetes at different ages. Type 1 diabetes is most commonly diagnosed in 10 to 14 year olds but can be diagnosed at any age. Researchers have hypothesised that whilst some people are have a genetic predisposition to type 1 diabetes,  [homepage](https://www.inzicontrols.net/battery/bbs/board.php?bo_table=qa&wr_id=1243368) there is likely to be an environmental factor that triggers the initial development of type 1 diabetes.<br>
 <br>Associations have been found between type 1 diabetes and a number of different viruses. Of these, enteroviruses have attracted the most interest from researchers. Studies have shown that enterovirus antibodies have been recorded at higher levels in pregnant mothers of children that gone on to develop type 1 diabetes. Higher frequencies of enterovirus infections have also been detected in children which develop type 1 diabetes when compared with siblings that have not developed the condition. Another theory put forward is that childhood vaccinations could increase the chances of developing type 1 diabetes. One researcher, Dr J B Classen has investigated incidences of type 1 diabetes in the human population as well as in animals. Dr Classen’s research indicates there could be a link between type 1 diabetes and childhood vaccinations such as smallpox, tuberculosis and Hib vaccines. The research has yet to be accepted as conclusive enough to change vaccination schedules. A link between vitamin D and type 1 diabetes has been drawn.<br>
 <br>Researchers have noted that countries with the highest incidences of type 1 diabetes tend to be located further from the equator. Countries such as the UK, Canada, Australia and the countries of Scandinavia all have notably high rates of type 1 diabetes. Studies have also shown that people with lower levels of vitamin D had a higher incidence rate of developing type 1 diabetes. A number of studies, including the EURODIAB Substudy 2, have shown that supplementation of vitamin D appears to lower the risk of developing type 1 diabetes. Increased demand on insulin has also been put forward as a contributing factor. A study, carried out by the University of Colorado and published in 2008, showed that a diet with high glycaemic index foods could speed up the progression to type 1 diabetes in children with signs of [islet autoimmunity](https://ajt-ventures.com/?s=islet%20autoimmunity). The growth phase that children go through in teenage years increases the amount of insulin released and could lead to extra stress on beta cells, raising the risk of the immune system attacking the insulin producing cells.<br>
 <br>If you are evaluating what organic allulose is and how it works, the next question is inevitable: what does it actually do inside the body? Sweetness without consequence sounds appealing, but formulators, healthcare professionals, and informed consumers want evidence - not marketing language. This article walks through the current scientific understanding of allulose and its effects on blood sugar, insulin, calorie intake, kidney function, liver metabolism, gut tolerance, and long-term safety. Every claim here traces back to published research or regulatory determinations. Allulose has a glycemic index of approximately zero. It does not raise blood glucose and does not trigger a meaningful insulin response. This is not a marginal effect - it is a consistent finding across clinical trials. A double-blind crossover study published in the Journal of Nutritional Science and Vitaminology demonstrated that 5 g of allulose consumed with a meal significantly reduced postprandial [Glyco Care blood sugar formula](http://polyinform.com.ua/user/AbigailHarker/) [Glyco Care glucose support](http://guilairo520.gain.tw/viewthread.php?tid=774669&extra=) elevation compared to the same meal without allulose.<br>
 <br>The mechanism appears to involve GLP-1 (glucagon-like peptide-1) stimulation: allulose encourages the release of this incretin hormone, which in turn slows gastric emptying and enhances insulin sensitivity. For food formulators, this means organic allulose sweetener can serve a functional role beyond sweetness - it actively helps blunt the glycemic impact of other carbohydrates in a formulation. For diabetic-friendly product claims, this is a meaningful differentiator. It is worth emphasizing that allulose does not lower blood sugar below normal levels. It moderates the spike. The effect is stabilizing, not hypoglycemic. Sugar delivers roughly 4 kcal per gram. Allulose delivers approximately 0.4 kcal per gram - about 90% fewer calories. The reason is straightforward: the human body largely cannot metabolize it. Unlike glucose, which is readily absorbed and oxidized for energy, allulose passes through metabolic pathways inefficiently. Most of what is absorbed is filtered by the kidneys and excreted in urine within 24 to 48 hours.<br>